Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes
- PMID: 20194590
- PMCID: PMC2863527
- DOI: 10.1128/IAI.00410-09
Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes
Abstract
Pregnancy-associated malaria is a severe clinical syndrome associated with the sequestration of Plasmodium falciparum-infected erythrocytes in the placenta. Placental binding is mediated by VAR2CSA, a member of the large and diverse P. falciparum erythrocyte membrane 1 (PfEMP1) protein family. To better understand if conserved regions in VAR2CSA can be targeted by antibodies, we immunized rabbits with VAR2CSA-DBL1 and -DBL5 recombinant proteins produced in Pichia pastoris and developed a panel of seven chondroitin sulfate A (CSA)-binding parasites from diverse geographic origins. Overall, no two parasites in the panel expressed the same VAR2CSA sequence. The DBL1 domains averaged 80% amino acid identity (range, 72 to 89%), and the DBL5 domains averaged 86% amino acid identity (range, 83 to 99%), similar to a broader sampling of VAR2CSA sequences from around the world. Whereas antibodies generated against the VAR2CSA-DBL1 recombinant protein had only limited breadth and reacted with three or four parasites in the panel, immunization with DBL5 recombinant proteins elicited broadly cross-reactive antibodies against all or most parasites in the panel, as well as to fresh clinical isolates from pregnant women. These findings demonstrate that the major PfEMP1 variant expressed by placental isolates exposes strain-transcendent epitopes that can be targeted by vaccination and may have application for pregnancy malaria vaccine development.
Figures


Similar articles
-
Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins.Malar J. 2011 Feb 11;10:36. doi: 10.1186/1475-2875-10-36. Malar J. 2011. PMID: 21314945 Free PMC article.
-
Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.Infect Immun. 2013 Apr;81(4):1031-9. doi: 10.1128/IAI.00978-12. Epub 2013 Jan 14. Infect Immun. 2013. PMID: 23319559 Free PMC article.
-
Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA.Infect Immun. 2008 Apr;76(4):1791-800. doi: 10.1128/IAI.01470-07. Epub 2008 Feb 4. Infect Immun. 2008. PMID: 18250177 Free PMC article.
-
Designing a VAR2CSA-based vaccine to prevent placental malaria.Vaccine. 2015 Dec 22;33(52):7483-8. doi: 10.1016/j.vaccine.2015.10.011. Epub 2015 Nov 26. Vaccine. 2015. PMID: 26469717 Free PMC article. Review.
-
Progress and Insights Toward an Effective Placental Malaria Vaccine.Front Immunol. 2021 Feb 25;12:634508. doi: 10.3389/fimmu.2021.634508. eCollection 2021. Front Immunol. 2021. PMID: 33717176 Free PMC article. Review.
Cited by
-
Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo.J Exp Med. 2012 Jan 16;209(1):93-107. doi: 10.1084/jem.20110762. Epub 2011 Dec 19. J Exp Med. 2012. PMID: 22184632 Free PMC article.
-
Var2CSA minimal CSA binding region is located within the N-terminal region.PLoS One. 2011;6(5):e20270. doi: 10.1371/journal.pone.0020270. Epub 2011 May 19. PLoS One. 2011. PMID: 21625526 Free PMC article.
-
Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins.Malar J. 2011 Feb 11;10:36. doi: 10.1186/1475-2875-10-36. Malar J. 2011. PMID: 21314945 Free PMC article.
-
High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.Infect Immun. 2012 Apr;80(4):1479-90. doi: 10.1128/IAI.00071-12. Epub 2012 Feb 13. Infect Immun. 2012. PMID: 22331427 Free PMC article.
-
Advances and challenges in malaria vaccine development.J Clin Invest. 2010 Dec;120(12):4168-78. doi: 10.1172/JCI44423. Epub 2010 Dec 1. J Clin Invest. 2010. PMID: 21123952 Free PMC article. Review.
References
-
- Avril, M., B. R. Kulasekara, S. O. Gose, C. Rowe, M. Dahlback, P. E. Duffy, M. Fried, A. Salanti, L. Misher, D. L. Narum, and J. D. Smith. 2008. Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA. Infect. Immun. 76:1791-1800. - PMC - PubMed
-
- Barfod, L., N. L. Bernasconi, M. Dahlback, D. Jarrossay, P. H. Andersen, A. Salanti, M. F. Ofori, L. Turner, M. Resende, M. A. Nielsen, T. G. Theander, F. Sallusto, A. Lanzavecchia, and L. Hviid. 2007. Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA. Mol. Microbiol. 63:335-347. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources